$MGTI
MGT Capital Investments Inc

2014 Q2 Form 10-Q Financial Statement

#000114420414031204 Filed on May 15, 2014

View on sec.gov

Income Statement

Concept 2014 Q2 2014 Q1 2013 Q1
Revenue $320.0K $85.00K $90.00K
YoY Change 377.61% -5.56% -57.14%
Cost Of Revenue $167.0K $49.00K $63.00K
YoY Change 735.0% -22.22% 57.5%
Gross Profit $153.0K $36.00K $23.00K
YoY Change 225.53% 56.52% -87.22%
Gross Profit Margin 47.81% 42.35% 25.56%
Selling, General & Admin $1.536M $1.264M $1.161M
YoY Change -50.1% 8.87% 43.33%
% of Gross Profit 1003.92% 3511.11% 5047.83%
Research & Development $53.00K $60.00K $0.00
YoY Change -100.0%
% of Gross Profit 34.64% 166.67% 0.0%
Depreciation & Amortization $190.0K $11.00K $4.000K
YoY Change 111.11% 175.0% -60.0%
% of Gross Profit 124.18% 30.56% 17.39%
Operating Expenses $1.680M $1.341M $1.161M
YoY Change -46.56% 15.5% 36.59%
Operating Profit -$1.527M -$1.305M -$1.138M
YoY Change -50.69% 14.67% 69.85%
Interest Expense $0.00 $0.00 $2.150M
YoY Change -100.0% -100.0%
% of Operating Profit
Other Income/Expense, Net $2.000K $3.000K $2.146M
YoY Change -100.06% -99.86%
Pretax Income -$1.525M -$1.302M $1.008M
YoY Change -77.14% -229.17% -248.24%
Income Tax -$1.000K -$10.00K $3.000K
% Of Pretax Income 0.3%
Net Earnings -$1.391M -$1.122M $1.061M
YoY Change -78.86% -205.75% -325.74%
Net Earnings / Revenue -434.69% -1320.0% 1178.89%
Basic Earnings Per Share -$0.13 $0.33
Diluted Earnings Per Share -$136.7K -$0.13 $0.24
COMMON SHARES
Basic Shares Outstanding 9.140M shares 8.796M shares 4.615M shares
Diluted Shares Outstanding 8.796M shares 3.076M shares

Balance Sheet

Concept 2014 Q2 2014 Q1 2013 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $2.400M $3.200M $2.700M
YoY Change -61.9% 18.52% -18.18%
Cash & Equivalents $2.425M $1.455M $2.678M
Short-Term Investments
Other Short-Term Assets $200.0K $200.0K $200.0K
YoY Change 0.0% 0.0% 0.0%
Inventory
Prepaid Expenses
Receivables $0.00 $51.00K $0.00
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $2.700M $3.425M $2.900M
YoY Change -59.17% 18.1% -21.62%
LONG-TERM ASSETS
Property, Plant & Equipment $0.00 $34.00K $0.00
YoY Change -100.0%
Goodwill $6.444M
YoY Change
Intangibles $2.306M
YoY Change
Long-Term Investments
YoY Change
Other Assets $100.0K $4.000K $2.000M
YoY Change 4900.0% -99.8%
Total Long-Term Assets $9.500M $8.926M $3.800M
YoY Change 17.01% 134.89% 3700.0%
TOTAL ASSETS
Total Short-Term Assets $2.700M $3.425M $2.900M
Total Long-Term Assets $9.500M $8.926M $3.800M
Total Assets $12.20M $12.35M $6.700M
YoY Change -17.19% 84.34% 76.32%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $400.0K $228.0K $200.0K
YoY Change 15.27% 14.0% -33.33%
Accrued Expenses $100.0K $134.0K $200.0K
YoY Change 1.01% -33.0% -50.0%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $1.300M $632.0K $400.0K
YoY Change 37.42% 58.0% -42.86%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $5.000M
YoY Change
Total Long-Term Liabilities $0.00 $0.00 $5.000M
YoY Change -100.0%
TOTAL LIABILITIES
Total Short-Term Liabilities $1.300M $632.0K $400.0K
Total Long-Term Liabilities $0.00 $0.00 $5.000M
Total Liabilities $2.900M $632.0K $6.200M
YoY Change 206.55% -89.81% 40.91%
SHAREHOLDERS EQUITY
Retained Earnings -$295.0M
YoY Change
Common Stock $305.0M
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $9.300M $9.782M $600.0K
YoY Change
Total Liabilities & Shareholders Equity $12.20M $12.35M $6.700M
YoY Change -17.19% 84.34% 76.32%

Cashflow Statement

Concept 2014 Q2 2014 Q1 2013 Q1
OPERATING ACTIVITIES
Net Income -$1.391M -$1.122M $1.061M
YoY Change -78.86% -205.75% -325.74%
Depreciation, Depletion And Amortization $190.0K $11.00K $4.000K
YoY Change 111.11% 175.0% -60.0%
Cash From Operating Activities -$1.040M -$1.420M -$770.0K
YoY Change 0.0% 84.42% 83.33%
INVESTING ACTIVITIES
Capital Expenditures $20.00K $41.00K $0.00
YoY Change -109.52% -100.0%
Acquisitions
YoY Change
Other Investing Activities -$50.00K $0.00
YoY Change -102.66%
Cash From Investing Activities -$40.00K -$40.00K $0.00
YoY Change -102.4% -100.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -1.150M 1.470M 0.000
YoY Change -137.7% -100.0%
NET CHANGE
Cash From Operating Activities -1.040M -1.420M -770.0K
Cash From Investing Activities -40.00K -40.00K 0.000
Cash From Financing Activities -1.150M 1.470M 0.000
Net Change In Cash -2.230M 10.00K -770.0K
YoY Change -160.6% -101.3% 75.0%
FREE CASH FLOW
Cash From Operating Activities -$1.040M -$1.420M -$770.0K
Capital Expenditures $20.00K $41.00K $0.00
Free Cash Flow -$1.060M -$1.461M -$770.0K
YoY Change 27.71% 89.74% 87.8%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2014Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
3220000 USD
CY2013Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
4642000 USD
CY2014Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
51000 USD
CY2013Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
43000 USD
CY2014Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
154000 USD
CY2013Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
132000 USD
CY2014Q1 us-gaap Assets Current
AssetsCurrent
3425000 USD
CY2014Q1 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
138000 USD
CY2013Q4 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
140000 USD
CY2014Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
34000 USD
CY2013Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
45000 USD
CY2014Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
2306000 USD
CY2014Q1 us-gaap Goodwill
Goodwill
6444000 USD
CY2014Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
4000 USD
CY2014Q1 us-gaap Assets
Assets
12351000 USD
CY2014Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
228000 USD
CY2014Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
134000 USD
CY2014Q1 us-gaap Deposit Liability Current
DepositLiabilityCurrent
245000 USD
CY2014Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2014Q1 us-gaap Common Stock Value
CommonStockValue
9000 USD
CY2014Q1 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
305009000 USD
CY2014Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-281000 USD
CY2014Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-294955000 USD
CY2013Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
228000 USD
CY2014Q1 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
25000 USD
CY2013Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
94000 USD
CY2014Q1 us-gaap Liabilities Current
LiabilitiesCurrent
632000 USD
CY2014Q1 us-gaap Liabilities
Liabilities
632000 USD
CY2013Q4 us-gaap Assets Current
AssetsCurrent
4817000 USD
CY2013Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
2423000 USD
CY2013Q4 us-gaap Goodwill
Goodwill
6444000 USD
CY2013Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
4000 USD
CY2013Q4 us-gaap Assets
Assets
13873000 USD
CY2013Q4 us-gaap Deposit Liability Current
DepositLiabilityCurrent
647000 USD
CY2013Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
16000 USD
CY2013Q4 us-gaap Liabilities Current
LiabilitiesCurrent
985000 USD
CY2013Q4 us-gaap Liabilities
Liabilities
985000 USD
CY2013Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2013Q4 us-gaap Common Stock Value
CommonStockValue
9000 USD
CY2013Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
304886000 USD
CY2013Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-281000 USD
CY2013Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-293833000 USD
CY2013Q4 us-gaap Stockholders Equity
StockholdersEquity
10781000 USD
CY2013Q4 us-gaap Minority Interest
MinorityInterest
2107000 USD
CY2013Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
13873000 USD
CY2013Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2013Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
75000000 shares
CY2013Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
8848686 shares
CY2013Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
8848686 shares
CY2014Q1 us-gaap Stockholders Equity
StockholdersEquity
9782000 USD
CY2014Q1 us-gaap Minority Interest
MinorityInterest
1937000 USD
CY2014Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
11719000 USD
CY2013Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
12888000 USD
CY2014Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
12351000 USD
CY2014Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2014Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
75000000 shares
CY2014Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
8894686 shares
CY2014Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
8894686 shares
CY2014Q1 us-gaap Use Of Estimates
UseOfEstimates
<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> <i>Use of estimates and assumptions and critical accounting estimates and assumptions</i> &#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> &#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 37.8pt; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">The preparation of financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date(s) of the financial statements and the reported amounts of revenues and expenses during the reporting period(s).</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 37.8pt; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 37.8pt; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">Critical accounting estimates are estimates for which (a) the nature of the estimate is material due to the levels of subjectivity and judgment necessary to account for highly uncertain matters or the susceptibility of such matters to change and (b) the impact of the estimate on financial condition or operating performance is material. The Company&#8217;s critical accounting estimates and assumptions affecting the financial statements were:</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> &#160;</div> <table style="MARGIN-TOP: 0pt; FONT: 10pt Times New Roman, Times, Serif; MARGIN-BOTTOM: 0pt" cellspacing="0" cellpadding="0" width="100%"> <tr style="VERTICAL-ALIGN: top"> <td style="WIDTH: 31.65pt"></td> <td style="WIDTH: 18pt"> <div>a)</div> </td> <td style="TEXT-ALIGN: justify"> <div><i>Allowance for doubtful accounts:</i> Management&#8217;s estimate of the allowance for doubtful accounts is based on historical sales, historical loss levels, and an analysis of the collectability of individual accounts; and general economic conditions that may affect a client&#8217;s ability to pay. The Company evaluated the key factors and assumptions used to develop the allowance in determining that it is reasonable in relation to the financial statements taken as a whole.</div> </td> </tr> </table> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px 0pt 49.65pt; FONT: 10pt Times New Roman, Times, Serif" align="justify">&#160;</div> <table style="MARGIN-TOP: 0pt; FONT: 10pt Times New Roman, Times, Serif; MARGIN-BOTTOM: 0pt" cellspacing="0" cellpadding="0" width="100%"> <tr style="VERTICAL-ALIGN: top"> <td style="WIDTH: 31.65pt"></td> <td style="WIDTH: 18pt"> <div>b)</div> </td> <td style="TEXT-ALIGN: justify"> <div><i>Fair value of long&#150;lived assets:</i> Fair value is generally determined using the asset&#8217;s expected future discounted cash flows or market value, if readily determinable. If long&#150;lived assets are determined to be recoverable, but the newly determined remaining estimated useful lives are shorter than originally estimated, the net book values of the long&#150;lived assets are depreciated over the newly determined remaining estimated useful lives. The Company considers the following to be some examples of important indicators that may trigger an impairment review: (i) significant under&#150;performance or losses of assets relative to expected historical or projected future operating results; (ii) significant changes in the manner or use of assets or in the Company&#8217;s overall strategy with respect to the manner or use of the acquired assets or changes in the Company&#8217;s overall business strategy; (iii) significant negative industry or economic trends; (iv) increased competitive pressures; (v) a significant decline in the Company&#8217;s stock price for a sustained period of time; and (vi) regulatory changes. The Company evaluates acquired assets for potential impairment indicators at least annually and more frequently upon the occurrence of such events.</div> </td> </tr> </table> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px 0pt 49.65pt; FONT: 10pt Times New Roman, Times, Serif" align="justify">&#160;</div> <table style="MARGIN-TOP: 0pt; FONT: 10pt Times New Roman, Times, Serif; MARGIN-BOTTOM: 0pt" cellspacing="0" cellpadding="0" width="100%"> <tr style="VERTICAL-ALIGN: top"> <td style="WIDTH: 31.65pt"></td> <td style="WIDTH: 18pt"> <div>c)</div> </td> <td style="TEXT-ALIGN: justify"> <div><i>Valuation</i> <i>allowance for deferred tax assets:</i> Management assumes that the realization of the Company&#8217;s net deferred tax assets resulting from its net operating loss (&#8220;NOL&#8221;) carry&#150;forwards for Federal income tax purposes that may be offset against future taxable income was not considered more likely than not and accordingly, the potential tax benefits of the net loss carry&#150;forwards are offset by a full valuation allowance. Management made this assumption based on (a) the Company has incurred recurring losses, (b) general economic conditions, and (c) its ability to raise additional funds to support its daily operations by way of a public or private offering, among other factors.</div> </td> </tr> </table> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px 0pt 49.65pt; FONT: 10pt Times New Roman, Times, Serif"> &#160;&#160;</div> <table style="MARGIN-TOP: 0pt; FONT: 10pt Times New Roman, Times, Serif; MARGIN-BOTTOM: 0pt" cellspacing="0" cellpadding="0" width="100%"> <tr style="VERTICAL-ALIGN: top"> <td style="WIDTH: 31.65pt"></td> <td style="WIDTH: 18pt"> <div>d)</div> </td> <td style="TEXT-ALIGN: justify"> <div><i>Estimates and assumptions used in valuation of equity instruments:</i> Management estimates expected term of share options and similar instruments, expected volatility of the Company&#8217;s common shares and the method used to estimate it, expected annual rate of quarterly dividends, and risk free rate(s) to value share options and similar instruments.</div> </td> </tr> </table> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> &#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 37.8pt; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">These significant accounting estimates or assumptions bear the risk of change due to the fact that there are uncertainties attached to these estimates or assumptions, and certain estimates or assumptions are difficult to measure or value.</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 37.8pt; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 37.8pt; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">Management bases its estimates on historical experience and on various assumptions that are believed to be reasonable in relation to the financial statements taken as a whole under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources.</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 37.8pt; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 37.8pt; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">Management regularly evaluates the key factors and assumptions used to develop the estimates utilizing currently available information, changes in facts and circumstances, historical experience and reasonable assumptions. After such evaluations, if deemed appropriate, those estimates are adjusted accordingly. Actual results could differ from those estimates.</div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>
CY2014Q1 us-gaap Technology Services Revenue
TechnologyServicesRevenue
43000 USD
CY2014Q1 us-gaap Sales Revenue Services Gross
SalesRevenueServicesGross
0 USD
CY2013Q1 mgt Sales Revenue Gaming Gross
SalesRevenueGamingGross
0 USD
CY2014Q1 mgt Sales Revenue Gaming Gross
SalesRevenueGamingGross
42000 USD
CY2014Q1 us-gaap Revenues
Revenues
85000 USD
CY2013Q1 us-gaap Other Cost Of Services
OtherCostOfServices
63000 USD
CY2013Q1 mgt Cost Of Services Gaming
CostOfServicesGaming
0 USD
CY2013Q1 us-gaap Cost Of Revenue
CostOfRevenue
63000 USD
CY2013Q1 us-gaap Gross Profit
GrossProfit
23000 USD
CY2013Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
1161000 USD
CY2013Q1 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
0 USD
CY2014Q1 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
17000 USD
CY2014Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
60000 USD
CY2014Q1 us-gaap Operating Expenses
OperatingExpenses
1341000 USD
CY2014Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-1305000 USD
CY2014Q1 mgt Interest And Other Non Operating Income Expense
InterestAndOtherNonOperatingIncomeExpense
3000 USD
CY2013Q1 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-2122000 USD
CY2014Q1 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
0 USD
CY2013Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
2146000 USD
CY2014Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
3000 USD
CY2013Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
1008000 USD
CY2014Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-1302000 USD
CY2013Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
3000 USD
CY2014Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-10000 USD
CY2013Q1 us-gaap Profit Loss
ProfitLoss
1005000 USD
CY2014Q1 us-gaap Profit Loss
ProfitLoss
-1292000 USD
CY2013Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-56000 USD
CY2014Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-170000 USD
CY2013Q1 us-gaap Net Income Loss
NetIncomeLoss
1061000 USD
CY2014Q1 us-gaap Net Income Loss
NetIncomeLoss
-1122000 USD
CY2013Q1 us-gaap Dividends Preferred Stock Stock
DividendsPreferredStockStock
61000 USD
CY2014Q1 us-gaap Dividends Preferred Stock Stock
DividendsPreferredStockStock
0 USD
CY2013Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
1000000 USD
CY2014Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-1122000 USD
CY2013Q1 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
1005000 USD
CY2014Q1 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-1292000 USD
CY2013Q1 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
0 USD
CY2014Q1 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
0 USD
CY2013Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
1005000 USD
CY2014Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-1292000 USD
CY2014Q1 us-gaap Convertible Preferred Stock Shares Issued Upon Conversion
ConvertiblePreferredStockSharesIssuedUponConversion
9555 shares
CY2014Q1 mgt Warrants Antidilutive
WarrantsAntidilutive
920829 shares
CY2014Q1 us-gaap Goodwill Acquired During Period
GoodwillAcquiredDuringPeriod
0 USD
CY2014Q1 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
603000 USD
CY2013Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
486000 USD
CY2014Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
2306000 USD
CY2013Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
2423000 USD
CY2014Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
489000 USD
CY2014Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
489000 USD
CY2014Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
408000 USD
CY2014Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
391000 USD
CY2014Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
363000 USD
CY2014Q1 us-gaap Finite Lived Intangible Assets Amortization Expense After Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive
166000 USD
CY2013Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
52000 USD
CY2014Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
117000 USD
CY2014Q1 mgt Warrants Term
WarrantsTerm
five-year
CY2014Q1 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights
3.85
CY2013Q2 us-gaap Convertible Preferred Stock Shares Issued Upon Conversion
ConvertiblePreferredStockSharesIssuedUponConversion
1123809 shares
CY2013Q2 us-gaap Stock Issued During Period Shares Conversion Of Convertible Securities
StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities
1125763 shares
CY2012Q4 mgt Cash Maintenance Provision Limit On Shares
CashMaintenanceProvisionLimitOnShares
345092 shares
CY2013Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
52667 shares
CY2014Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
46000 shares
CY2014Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
2000 shares
CY2014Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
0 shares
CY2014Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
96667 shares
CY2013Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
5.20
CY2014Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
2.58
CY2014Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
3.68
CY2014Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
0
CY2014Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
3.64
CY2013Q1 us-gaap Share Based Compensation
ShareBasedCompensation
359000 USD
CY2014Q1 us-gaap Share Based Compensation
ShareBasedCompensation
123000 USD
CY2013Q4 mgt Share Based Compensation Arrangement By Share Based Payment Award Warrants Outstanding
ShareBasedCompensationArrangementByShareBasedPaymentAwardWarrantsOutstanding
920825 shares
CY2014Q1 mgt Share Based Compensation Arrangement By Share Based Payment Award Warrants Issued
ShareBasedCompensationArrangementByShareBasedPaymentAwardWarrantsIssued
0 shares
CY2014Q1 mgt Share Based Compensation Arrangement By Share Based Payment Award Warrants Exercised
ShareBasedCompensationArrangementByShareBasedPaymentAwardWarrantsExercised
0 shares
CY2014Q1 mgt Share Based Compensation Arrangement By Share Based Payment Award Warrants Expired
ShareBasedCompensationArrangementByShareBasedPaymentAwardWarrantsExpired
0 shares
CY2014Q1 mgt Share Based Compensation Arrangement By Share Based Payment Award Warrants Outstanding
ShareBasedCompensationArrangementByShareBasedPaymentAwardWarrantsOutstanding
920825 shares
CY2013Q4 mgt Share Based Compensation Arrangement By Share Based Payment Award Weighted Average Exercise Price Warrants Outstanding
ShareBasedCompensationArrangementByShareBasedPaymentAwardWeightedAverageExercisePriceWarrantsOutstanding
3.46
CY2014Q1 mgt Share Based Compensation Arrangement By Share Based Payment Award Weighted Average Exercise Price Warrants Issued
ShareBasedCompensationArrangementByShareBasedPaymentAwardWeightedAverageExercisePriceWarrantsIssued
0
CY2014Q1 mgt Share Based Compensation Arrangement By Share Based Payment Award Weighted Average Exercise Price Warrants Exercised
ShareBasedCompensationArrangementByShareBasedPaymentAwardWeightedAverageExercisePriceWarrantsExercised
0
CY2014Q1 mgt Share Based Compensation Arrangement By Share Based Payment Award Weighted Average Exercise Price Warrants Expired
ShareBasedCompensationArrangementByShareBasedPaymentAwardWeightedAverageExercisePriceWarrantsExpired
0
CY2014Q1 mgt Share Based Compensation Arrangement By Share Based Payment Award Weighted Average Exercise Price Warrants Outstanding
ShareBasedCompensationArrangementByShareBasedPaymentAwardWeightedAverageExercisePriceWarrantsOutstanding
3.46
CY2014Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
415000 shares
CY2014Q1 mgt Percentage Of Stockholder Incentive Stock Option Granted On Date Of Grant
PercentageOfStockholderIncentiveStockOptionGrantedOnDateOfGrant
0.1 pure
CY2014Q1 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
283000 USD
CY2014Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P9M11D
CY2014Q1 us-gaap Stock Issued During Period Value Restricted Stock Award Gross
StockIssuedDuringPeriodValueRestrictedStockAwardGross
41000 USD
CY2013Q4 mgt Cash Consideration Payable Upon Execution Of Consulting Agreement
CashConsiderationPayableUponExecutionOfConsultingAgreement
20000 USD
CY2013Q4 mgt Common Stock Issuable Upon Execution Of Consulting Agreement
CommonStockIssuableUponExecutionOfConsultingAgreement
10000 shares
CY2014Q1 mgt Stock Issuance Costs
StockIssuanceCosts
57000 USD
CY2014Q1 mgt Common Stock Shares Issued Upon Execution Of Consulting Agreement
CommonStockSharesIssuedUponExecutionOfConsultingAgreement
20000 shares
CY2013Q1 us-gaap Depreciation
Depreciation
4000 USD
CY2014Q1 us-gaap Depreciation
Depreciation
11000 USD
CY2013Q1 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
2122000 USD
CY2014Q1 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
0 USD
CY2013Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-9000 USD
CY2014Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
8000 USD
CY2013Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-107000 USD
CY2014Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
22000 USD
CY2013Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-39000 USD
CY2014Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
0 USD
CY2013Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-95000 USD
CY2014Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
40000 USD
CY2013Q1 us-gaap Increase Decrease In Other Current Liabilities
IncreaseDecreaseInOtherCurrentLiabilities
-46000 USD
CY2014Q1 us-gaap Increase Decrease In Other Current Liabilities
IncreaseDecreaseInOtherCurrentLiabilities
9000 USD
CY2013Q1 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-766000 USD
CY2014Q1 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-1424000 USD
CY2013Q1 mgt Release Of Restricted Cash And Cash Equivalents
ReleaseOfRestrictedCashAndCashEquivalents
0 USD
CY2014Q1 mgt Release Of Restricted Cash And Cash Equivalents
ReleaseOfRestrictedCashAndCashEquivalents
2000 USD
CY2013Q1 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
0 USD
CY2014Q1 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
2000 USD
CY2013Q1 us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
1000 USD
CY2014Q1 us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
0 USD
CY2013Q1 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-765000 USD
CY2014Q1 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-1422000 USD
CY2012Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
3443000 USD
CY2013Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
2678000 USD
CY2013Q1 us-gaap Dividends Preferred Stock Paidinkind
DividendsPreferredStockPaidinkind
61000 USD
CY2014Q1 us-gaap Dividends Preferred Stock Paidinkind
DividendsPreferredStockPaidinkind
0 USD
CY2014Q1 us-gaap Property Plant And Equipment Additions
PropertyPlantAndEquipmentAdditions
0 USD
CY2014Q1 us-gaap Finitelived Intangible Assets Acquired1
FinitelivedIntangibleAssetsAcquired1
0 USD
CY2014Q1 us-gaap Operating Leases Future Minimum Payments Due Current
OperatingLeasesFutureMinimumPaymentsDueCurrent
75000 USD
CY2014Q1 us-gaap Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
0 USD
CY2014Q1 us-gaap Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
75000 USD
CY2014Q1 mgt Operating Leases Expenses For Rental Deposit Total
OperatingLeasesExpensesForRentalDepositTotal
3000 USD
CY2013Q2 mgt Operating Leases Expenses For Rental Deposit Total
OperatingLeasesExpensesForRentalDepositTotal
2000 USD
CY2011Q3 mgt Operating Leases Expenses For Rental Deposit Total
OperatingLeasesExpensesForRentalDepositTotal
240000 USD
CY2014Q1 mgt Operating Leases Rental Payments Terms
OperatingLeasesRentalPaymentsTerms
P6M
CY2013Q2 mgt Operating Leases Rental Payments Terms
OperatingLeasesRentalPaymentsTerms
P24M
CY2011Q3 mgt Operating Leases Rental Payments Terms
OperatingLeasesRentalPaymentsTerms
P39M
CY2014Q1 us-gaap Lease Expiration Date1
LeaseExpirationDate1
2014-06-30
CY2013Q2 us-gaap Lease Expiration Date1
LeaseExpirationDate1
2014-10-31
CY2011Q3 us-gaap Lease Expiration Date1
LeaseExpirationDate1
2014-11-30
CY2014Q1 mgt Refundable Rental Deposit
RefundableRentalDeposit
3000 USD
CY2013Q2 mgt Refundable Rental Deposit
RefundableRentalDeposit
2000 USD
CY2011Q3 mgt Refundable Rental Deposit
RefundableRentalDeposit
39000 USD
CY2014Q1 mgt Payment Towards Consultation Services
PaymentTowardsConsultationServices
9000 USD
CY2013Q1 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
17000 USD
CY2014Q1 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
30000 USD
CY2014Q1 dei Document Type
DocumentType
10-Q
CY2014Q1 dei Amendment Flag
AmendmentFlag
false
CY2014Q1 dei Document Period End Date
DocumentPeriodEndDate
2014-03-31
CY2014Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2014
CY2014Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2014Q1 dei Trading Symbol
TradingSymbol
MGT
CY2014Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
9139603 shares
CY2014Q1 dei Entity Registrant Name
EntityRegistrantName
MGT CAPITAL INVESTMENTS INC
CY2014Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001001601
CY2014Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2014Q1 dei Entity Filer Category
EntityFilerCategory
Smaller Reporting Company
CY2013Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.33
CY2014Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.13
CY2013Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.24
CY2014Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.13
CY2013Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
4614577 shares
CY2014Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
8796041 shares
CY2013Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
3075802 shares
CY2014Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
8796041 shares
CY2013Q1 mgt Increase Decrease In Deposit Liability
IncreaseDecreaseInDepositLiability
0 USD
CY2014Q1 mgt Increase Decrease In Deposit Liability
IncreaseDecreaseInDepositLiability
-402000 USD
CY2014Q1 mgt Sale Of Stock Offering Price
SaleOfStockOfferingPrice
8500000 USD
CY2014Q1 mgt Manager Fee Percentage On Gross Sales Price
ManagerFeePercentageOnGrossSalesPrice
0.030 pure
CY2014Q1 us-gaap Restricted Cash And Investments
RestrictedCashAndInvestments
3358000 USD
CY2013Q2 us-gaap Proceeds From Divestiture Of Interest In Consolidated Subsidiaries
ProceedsFromDivestitureOfInterestInConsolidatedSubsidiaries
1500000 USD
CY2014Q1 mgt Additional Lump Sum Payment
AdditionalLumpSumPayment
15000000 USD
CY2014Q1 mgt Warrants Exchanged For Common Stock
WarrantsExchangedForCommonStock
52500 shares
CY2014Q1 mgt Warrants Expiry Description
WarrantsExpiryDescription
all issued warrants are exercisable and expire through 2017.

Files In Submission

Name View Source Status
0001144204-14-031204-index-headers.html Edgar Link pending
0001144204-14-031204-index.html Edgar Link pending
0001144204-14-031204.txt Edgar Link pending
0001144204-14-031204-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
Financial_Report.xlsx Edgar Link pending
mgt-20140331.xml Edgar Link completed
mgt-20140331.xsd Edgar Link pending
mgt-20140331_cal.xml Edgar Link unprocessable
mgt-20140331_def.xml Edgar Link unprocessable
mgt-20140331_lab.xml Edgar Link unprocessable
mgt-20140331_pre.xml Edgar Link unprocessable
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
v378139_10q.htm Edgar Link pending
v378139_ex31-1.htm Edgar Link pending
v378139_ex31-2.htm Edgar Link pending
v378139_ex32-1.htm Edgar Link pending
v378139_ex32-2.htm Edgar Link pending